Tritonix.ai

News / Taiwan / cnyes

Tanvex BioPharma August Revenue Skyrockets 210% YoY

Health Technology · Biotechnology · cnyes · 2026-09-10

6541

Tanvex BioPharma (6541) reported a 210.14% year-over-year revenue surge for August 2026, with cumulative year-to-date growth reaching 250.13%.

What Happened

Revenue Performance: Tanvex BioPharma (6541) announced August 2026 revenue of NT$73.18 million, representing a substantial year-over-year growth of 210.14% and a 36.06% monthly increase.

Year-to-Date Results: The company's cumulative revenue for the first eight months of 2026 reached NT$480 million, marking a year-to-date growth rate of 250.13%.

Market Performance: With a current share price of NT$31.55, the stock rose 0.96% over the last five days, outperforming the biotech and healthcare sector index which declined by 1.69%.

Business Profile: Tanvex BioPharma is primarily engaged in the research, development, manufacturing, and commercialization of biosimilars and novel drugs.

Read original

More in Health Technology

Rare Disease Families Face Regulatory Hurdles in Quest for Gene Therapy Access

Health Technology · cnbc · 2026-09-10

The struggle of the Stecker family to secure gene therapy for their son highlights the systemic challenges and ethical dilemmas in treating rare childhood diseases.

GILD

Alvogen's Subsidiary Lotus Reports 81% Surge in August Revenue

Health Technology · cnyes · 2026-09-10

Lotus Pharmaceutical reported August 2026 revenue of NT$2.11 billion, an 81.68% YoY increase, with cumulative year-to-date growth reaching nearly 70%.

1795

Lotus Pharmaceutical Reports 81.6% Revenue Surge in August, Driven by Alvogen Integration

Health Technology · economic_daily · 2026-09-10

Lotus Pharmaceutical announced an 81.67% year-over-year revenue increase for August, reaching NT$2.107 billion, fueled by strong B2B growth and the Alvogen merger.

1795

Latest in Taiwan

Fubon NASDAQ-100 ETF (00662) Announces 1-for-5 Share Split, Trading Resumes Nov 17

Finance · cnyes · 2026-09-10

Fubon Asset Management is splitting its NASDAQ-100 ETF (00662) at a 5-to-1 ratio to lower unit prices and improve accessibility for retail investors.

00662

Yung-Jie Reports Record August Revenue Driven by Sports Brand Demand and Real Estate Deliveries

Process Industries · cnyes · 2026-09-10

Yung-Jie achieved record-breaking revenue for August and the first eight months of 2026, supported by strong demand for eco-friendly shoe materials and property sales.

4714

China Airlines Reports August Revenue of NT$21.9 Billion, Second-Highest on Record

Transportation · economic_daily · 2026-09-10

China Airlines achieved a 27.22% year-over-year revenue increase in August, driven by strong summer travel demand and robust air cargo shipments for AI and semiconductor equipment.

2610

Taiwan E-Payment Transaction Volume Hits NT$33 Billion in July Driven by Fuel Fee Payments

Technology Services · cnyes · 2026-09-10

Taiwan's electronic payment sector saw a surge in transaction volume to NT$33 billion in July, fueled by seasonal fuel fee payments and strong growth from JKO Pay.